| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |